Tev-408
Found 1 recent publications
Sep 2, 2026
16:52Calcalist
Business
Teva's vitiligo drug shows promising results for celiac disease treatment
Teva reported positive results in a clinical trial for the treatment of celiac disease. The trial met its primary endpoint, demonstrating that the TEV-408 antibody prevents intestinal damage.
Showing latest 50 articles for this tag